The China companion animal diagnostics market size is projected to reach US$ 806.73 million by 2031 from US$ 358.61 million in 2023. The market is expected to register a CAGR of 9.0% during 2023–2031. Improvements in diagnostic technologies that support the early detection of diseases are likely to bring in trends in the market.
The China companion animal diagnostics market size is expanding with the increasing number of infectious disease cases and understanding of the benefits of using point-of-care diagnostics to identify illnesses in animals. Point-of-care diagnostics (POCDs) are quick, easy-to-use, and portable diagnostic tools that can identify the state of a disease at the scene. Real-time PCR (qPCR) has been converted to a POCD platform in recent years. These completely automated devices integrate heat cycling, on-site reporting of results, and nucleic acid extraction. For example, the 10–35-kg MiniLab molecular diagnostic platform from Enigma Diagnostics is transported in the field and used for research purposes to validate the viruses that cause classical swine fever, avian influenza, foot-and-mouth disease, and African swine fever.
The higher adoption of companion animals and the increase in spending for the well-being of their pets are factors driving the growth of the China companion animal diagnostics market. Moreover, there has been an increase in the use of artificial intelligence (AI) and machine learning in pet companion animal diagnostics. AI-powered algorithms can be implemented in diagnostics to analyze large volumes of data to identify patterns and make predictions, which can help improve the accuracy and efficiency of diagnostic tests. For instance, in September 2022, SK Telecom Co., Ltd. announced the launch of X Caliber, an AI-based veterinary X-ray image diagnosis assistance service available in Asia Pacific. X Caliber is a web-based service that employs AI to evaluate dog X-ray pictures submitted by veterinarians. The results are sent back to the veterinarian in less than 30 seconds. Thus, the growing technological advancements in the field of animal diagnosis are likely to be instrumental in bringing new trends in the China companion animal diagnostics market.
Pets have become an important part of humans’ lives. Pet adoption is among the crucial components of animal welfare, giving homeless and abandoned animals a healthy chance to live a quality life. Also, more people prefer adopting pets over buying them under the influence of social media influencers. According to the Animals Asia Foundation, the cat and dog pet population exceeded 125 million in 2023 in urban China. With the surge in pet adoption, pet parents are becoming more conscious about the well-being of their pets. This has led to the growing awareness of disease diagnosis among pet parents, owing to which the companion animal diagnostics market in China is gaining significant traction. Pet expenses have been rising in China as a result of rising premiumization and the availability of more expensive goods from younger consumers. Furthermore, because of rising disposable income and new pet food kinds hitting the market, pet parents' purchasing power has changed. The country's pet expenditure rose by 26.1% between 2017 and 2022 as a result of these reasons.
With six pet cafes running in Shanghai and an online platform called Boqii Mall that offers pet supplies, a place for pet parents to share their experiences, and other services that pet parents need, the pet ecosystem in the nation has changed. The adoption of cats in the nation is likewise influenced by these factors. In China, the number of pets—including cats—in urban areas has increased. Between 2018 and 2020, the pet population grew by 10.2%, reaching 100.8 million in urban areas.
In companion care, precision medicine is revolutionizing the landscape, offering tailored diagnostics and treatments that may benefit pet animal welfare and health. Precision medicine enables veterinarians to provide more accurate diagnoses, customized treatments, and improved outcomes using genomic sequencing, personalized diagnostics, and targeted therapies. The understanding of animal genetics is expected to be enhanced by the development of more sophisticated tools and techniques to diagnose and treat pet animals more precisely. As a result of precision medicine in pet care, animals at risk for certain diseases can be identified at an early stage, and targeted interventions can be implemented. Further, nutritional strategies can be developed based on an animal's genetic profile using precision medicine. Veterinary professionals can optimize diets to support animal health, prevent diseases, and improve performance based on an animal's unique nutritional needs and genetic variations. As a result of precision medicine, selective breeding practices can be obtained by identifying genes associated with desirable traits and disease risks. With this knowledge, breeders can make better decisions about breeding, reduce the occurrence of inherited disorders, and increase genetic diversity of animal populations. Thus, precision medicine in pet care can propel the growth of the companion animal diagnostics market in the future.
Key segments that contributed to the derivation of the China companion animal diagnostics market analysis are technique, product, application, companion animal type, end user, and geography.
The companion animal diagnostics market in China is growing with efforts for the reclassification of companion animals, rising awareness about animal health and zoonotic diseases, and increasing frequency of animal disease outbreaks. In April 2020, the Ministry of Agriculture and Rural Affairs announced a mandate to reclassify dogs as “companion animals” instead of “livestock.” Additionally, various cities in China have taken initiatives to ban the consumption of companion animals such as dogs and cats. In 2020, Shenzhen became the first city in China to prohibit dog and cat meat consumption, followed by Zhuhai. The Government of the People’s Republic of China has been taking actions to deal with the challenges posed by animal disease burden through disease reporting system establishment, laws and regulations, special projects implementation for primary infectious diseases, foreign disease surveillance, and health education. In March 2016, the government released national standards governing how laboratory animals are treated. The aim of setting these standards was to encourage ethically appropriate handling of animals and improve China’s prospects for international research collaborations. Thus, government support to enhance animal health is likely to favor the growth of the companion animal diagnostics market.
Various initiatives by leading players operating in the China Companion Animal Diagnostics Market are listed below:
A few prominent players operating in the China companion animal diagnostics market are
ARI Medical Technology Co Ltd, Heska Corp, Innovative Diagnostics SAS, i-SENS Inc, Tianjin
LOCMEDT Technologies Co Ltd, Universal Biosensors Inc, Zoetis Inc, Elanco Animal Health Inc,
Chengdu Seamaty Technology Co., Ltd, Shenzhen Mindray Animal Medical Technology Co., LTD . These companies focus on growth strategies such as new product launches and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 358.61 Million |
| Market Size by 2031 | US$ 806.73 Million |
| Global CAGR (2023 - 2031) | 9.0% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Technique
|
| Regions and Countries Covered | China
|
| Market leaders and key company profiles |
The increasing adoption of pets for companionship and an upsurge in pet spending are the most influential factors responsible for the market growth.
The China companion animal diagnostics market is estimated to register a CAGR of 9.0% from 2023 to 2031.
The China companion animal diagnostics market is estimated to reach US$ 806.73 million by 2031.
Demeditec Diagnostics GmbH, ARI Medical Technology Co Ltd, Tianjin LOCMEDT Technologies Co Ltd, Heska Corp, Innovative Diagnostics SAS, i-SENS Inc, Universal Biosensors Inc, Immunology Consultants Laboratory Inc, Zoetis Inc, and Elabscience Biotechnology Inc. are among the key players in the China Companion Animal Diagnostics Market.